Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 6/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 2/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | CCKAR | P32238 | 2/20 | 0.43 |
| ▸ | CCKBR | P32239 | 2/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7668103 | 1.00 | SCN9A (0.48) | SCN9AHDAC8AKT1MMP8MMP3 | |
| SCHEMBL3667405 | 0.73 | HDAC8 (0.64) | HDAC8AKT1CTSSCTSLCTSB | |
| SCHEMBL3667404 | 0.73 | HDAC8 (0.64) | HDAC8AKT1CTSSCTSLCTSB | |
| SCHEMBL7539970 | 0.73 | ITGB3 (0.46) | HDAC8MMP8MMP3 | |
| SCHEMBL9610766 | 0.73 | HDAC8 (0.72) | HDAC8AKT1CTSSCTSLCTSB | |
| SCHEMBL3944495 | 0.73 | HDAC8 (0.72) | HDAC8AKT1CTSSCTSLCTSB | |
| SCHEMBL3004725 | 0.72 | THRB (0.59) | SCN9AHDAC8AKT1CTSSCTSL | |
| SCHEMBL3004726 | 0.72 | THRB (0.59) | SCN9AHDAC8AKT1CTSSCTSL | |
| SCHEMBL7543230 | 0.72 | ITGB3 (0.46) | HDAC8MMP8MMP3 | |
| SCHEMBL2998957 | 0.72 | CTSS (0.50) | SCN9AHDAC8AKT1CTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6458784-B1 | PHARMACEUTICALLY ACTIVE BENZODIAZAPINE COMPOUNDS OF FORMULA (I) ARE DISCLOSED. THESE COMPOUNDS INHIBIT THE VITRONECTIN RECEPTOR AND ARE USEFUL FOR TREATMENT OF OSTEOPOROSIS. | SMITHKLINE BEECHAM CORPORATION | 2002-10-01 | — | — | US | disclosed |
| EP-0762882-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-0762882-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1996000574-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-01-11 | — | — | WO | disclosed |